Advocacy intelligence hub — real-time data for patient organizations
Pfizer — PHASE1
Addpharma Inc. — PHASE1
Addpharma Inc. — PHASE1
Pfizer — PHASE1
Syndeio Biosciences, Inc — PHASE1
Boryung Pharmaceutical Co., Ltd — PHASE1
APR Applied Pharma Research s.a. — PHASE1
Berlin-Chemie AG Menarini Group — PHASE1
Qilu Pharmaceutical Co., Ltd. — PHASE1
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Marina Cuchel, MD, PhD
University of Pennsylvania
Mark Underwood, MD
UC Davis
Aryan MF Jalal, M.B.CH.B
Rheumatology,Hawler medical uiversity,Kurdistan Board for medical specialities
Ibtihal HH Faraj, M-B.CH.B
Rheumatology,Hawler medical university
Min-Gul Kim, MD
Chonbuk National University Hospital
Eric Masson, Pharm.D., LICSW
Anapharm
📍 ATHOL, MA